Results 41 to 50 of about 8,269 (200)
Mutations of ETNK1 in aCML and CMML [PDF]
In this issue of Blood , Gambacorti-Passerini et al describe, for the first time, mutations of an ethanolamine kinase called ETNK1, which is physiologically involved in the first step of the phosphatidylethanolamine biosynthesis pathway. 1 The authors describe 2 recurrent point mutations of ETNK1 in 9% of atypical chronic myeloid leukemias (aCMLs ...
openaire +2 more sources
Abstract INTRODUCTION Recent studies have shown that OM-CMML and CMML have a similar clinical and biological profile. Since the proliferative-CMML (P-CMML) is the last-stage of CMML proliferative continuum and shows poor outcomes, it is expected that OM-CMML presents the best outcomes of these entities, as it represents an
David Roman-Bravo +11 more
openaire +1 more source
Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapy. [PDF]
Myelodysplastic Neoplasms (MDS) and Chronic Myelomonocytic Leukemia (CMML) are clonal disorders driven by progressively acquired somatic mutations in hematopoietic stem cells (HSCs).
Zanini, Fabio +25 more
core +1 more source
IntroductionChronic myelomonocytic leukemia (CMML) and myelodysplastic syndromes (MDS) with ring sideroblasts (RS) or SF3B1 mutation (MDS-RS/SF3B1) differ in many clinical features, but share others, such as anemia.
Blanca Xicoy +20 more
doaj +1 more source
Massive Right Atrial Thrombosis: Are You Brave Enough to Start Anticoagulation? A Case Report
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell disorder with overlapping myelodysplastic and myeloproliferative features.
Marco Bergonti +6 more
doaj +1 more source
CHRONIC MYELOMONOCYTIC LEUKEMIA - REVIEW AND CLINICAL EXPERIENCE OF THE HEMATOLOGY DEPARTMENT UMHAT "ST. MARINA" - VARNA [PDF]
Chronic myelomonocytic leukemia (CMML) is a rare de novo myeloid neoplasm that exhibits dysplastic and proliferative features at presentation. The diagnosis is problematic with several specific controversial issues.
Ilina Micheva +3 more
doaj +1 more source
Chronic myelomonocytic leukemia as a transformation from polycythemia vera
The hallmark of Polycythemia vera (PV) is the presence of JAK2V617F mutation and increased RBC mass. Chronic myelomonocytic leukemia (CMML) is defined as persistent blood absolute monocyte count (AMC) >/= 1 × 109/L for at least 3 months with myeloid cell
Mirela Andrei +3 more
doaj +1 more source
Chronic myelomonocytic leukemia (CMML) is a rare clonal haematological malignancy bearing characteristics of both myelodysplastic syndromes and myeloproliferative neoplasms. It primarily affects older people (median age at diagnosis ~72 years). There are
Konstantinos Liapis, Ioannis Kotsianidis
doaj +1 more source
Allogeneic Hematopoietic Stem Cell Transplantation for MDS and CMML: When and How?
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the only curative treatment in both MDS and CMML. In MDS, there is an increasing prevalence of high-risk MDS undergoing HSCT, whereas only a selected group of patients with low-risk ...
Gill, Harinder +3 more
core +1 more source
Allogeneic Transplant for CMML
Abstract Purpose of Review Chronic myelomonocytic leukemia (CMML) is a rare hematologic malignancy at the intersection of myelodysplastic (MDS) and myeloproliferative neoplasms, predominantly affecting older adults.
Gagelmann, Nico, Desai, Nihar
openaire +2 more sources

